## **Core Concept**
IPSID (immunoproliferative small intestinal disorder) is a rare, acquired, lymphoproliferative disorder primarily affecting the small intestine. It is characterized by the abnormal proliferation of plasma cells and lymphocytes in the intestinal mucosa. IPSID is often associated with malabsorption and is more common in certain geographic regions, particularly in the Middle East and North Africa.

## **Why the Correct Answer is Right**
The most common presentation in patients with IPSID includes chronic diarrhea, weight loss, and abdominal pain. Malabsorption leading to symptoms like diarrhea and weight loss is a hallmark due to the infiltration of the intestinal wall by proliferating lymphoplasmacytic cells, which compromises the normal absorptive function of the intestine.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While abdominal pain can be a feature, it is not the most distinctive or common presentation when considered alone.
- **Option B:** Malabsorption symptoms are indeed present but specifying "chronic diarrhea" and "weight loss" together (as in the correct answer) more accurately reflects the typical clinical presentation.
- **Option C:** This option might be considered if it accurately described a common presentation; however, without content, we infer its incorrectness based on the provided correct answer.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that IPSID can sometimes respond to antibiotic therapy, particularly in the early stages, suggesting a possible link with bacterial infections, such as *Campylobacter jejuni*. This is a high-yield fact for exams.

## **Correct Answer:** D. Chronic diarrhea and weight loss.